Patent Assignment
Reel/Frame 055322/0045
Change of Name
Recorded: 2021-02-18
Pages: 4
Assignor
NANGENEX NANOTECHNOLOGY INCORPORATED
Executed: 2020-09-01
Assignee
TAVANTA THERAPEUTICS HUNGARY INCORPORATED
MADARÁSZ VIKTOR UTCA 47-49., BUDAPEST, 1138, HUNGARY
Covered Properties
(2)
Pharmaceutical Formulation Containing Tadalafil
Pharmaceutical Formulation Containing Tadalafil
Application:
16/672,196 →
Publication:
US 2020/0061058
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 19, 2018
From: SZABÓNÉ ORDASI, BETTI; JORDÁN, TAMÁS; KÁRPÁTI, RICHÁRD BALÁZS; UJHELYI, ANDREA
To: DRUGGABILITY TECHNOLOGIES IP HOLDCO LIMITED
Reel/Frame 045592/0879 →
Assignment of Assignor's Interest
Mar 3, 2020
From: SZABÓNÉ ORDASI, BETTI; JORDÁN, TAMÁS; KÁRPÁTI, RICHÁRD BALÁZS; UJHELYI, ANDREA
To: DRUGGABILITY TECHNOLOGIES IP HOLDCO LIMITED
Reel/Frame 051998/0916 →
Merger
Mar 3, 2020
From: DRUGGABILITY TECHNOLOGIES IP HOLDCO LIMITED
To: NANGENEX NANOTECHNOLOGY INCORPORATED
Reel/Frame 052000/0924 →
Merger
Feb 18, 2021
From: DRUGGABILITY TECHNOLOGIES IP HOLDCO LIMITED
To: NANGENEX NANOTECHNOLOGY INCORPORATED
Reel/Frame 055321/0877 →